Arbutus Biopharma Corp (ABUS):企業の財務・戦略的SWOT分析

◆英語タイトル:Arbutus Biopharma Corp (ABUS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4335FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Arbutus Biopharma Corp (ABUS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Arbutus Biopharma Corp (Arbutus Biopharma), formerly Tekmira Pharmaceuticals Corp, focuses on the discovery, development, and commercialization of proprietary drugs and drug delivery systems indicated for the treatment of chronic hepatitis B infection (HBV). Its pipeline includes capsid assembly inhibitors: AB-729, AB-836 and a HBV RNA destabilizer. The company develops product candidates based on its lipid nanoparticle (LNP) delivery technology. Arbutus Biopharma works in partnership and collaboration with Genevant Sciences Inc, Alnylam Pharmaceuticals Inc, Acrotech Biopharma LLC and Gritstone Oncology. It operates in the US and Canada. Arbutus Biopharma is headquartered in Warminster, Pennsylvania, the US.

Arbutus Biopharma Corp Key Recent Developments

Apr 28,2021: Arbutus to Report First Quarter 2021 Financial Results and Provide Corporate Update
Mar 04,2021: Arbutus Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update
Feb 22,2021: Arbutus to Report Fourth Quarter and Year End 2020 Financial Results and Provide Corporate Update
Jan 25,2021: Arbutus announces 2021 corporate objectives and provides financial update
Nov 05,2020: Arbutus reports third quarter 2020 financial results and provides corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Arbutus Biopharma Corp – Key Facts
Arbutus Biopharma Corp – Key Employees
Arbutus Biopharma Corp – Key Employee Biographies
Arbutus Biopharma Corp – Major Products and Services
Arbutus Biopharma Corp – History
Arbutus Biopharma Corp – Company Statement
Arbutus Biopharma Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Arbutus Biopharma Corp – Business Description
Business Segment: Non-Cash Royalty Revenue
Performance
Business Segment: Revenue from Collaborations and Licenses
Performance
R&D Overview
Arbutus Biopharma Corp – Corporate Strategy
Arbutus Biopharma Corp – SWOT Analysis
SWOT Analysis – Overview
Arbutus Biopharma Corp – Strengths
Arbutus Biopharma Corp – Weaknesses
Arbutus Biopharma Corp – Opportunities
Arbutus Biopharma Corp – Threats
Arbutus Biopharma Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Arbutus Biopharma Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 28, 2021: Arbutus to Report First Quarter 2021 Financial Results and Provide Corporate Update
Mar 04, 2021: Arbutus Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update
Feb 22, 2021: Arbutus to Report Fourth Quarter and Year End 2020 Financial Results and Provide Corporate Update
Jan 25, 2021: Arbutus announces 2021 corporate objectives and provides financial update
Nov 05, 2020: Arbutus reports third quarter 2020 financial results and provides corporate update
Aug 07, 2020: Arbutus reports second quarter 2020 financial results and provides corporate update
May 11, 2020: Arbutus reports first quarter 2020 financial results, provides pipeline update and announces new research initiative to identify novel antiviral therapies for the treatment of coronavirus infections
Mar 05, 2020: Arbutus reports fourth quarter and year end 2019 financial results, confirms 2020 corporate objectives and provides pipeline update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Arbutus Biopharma Corp, Key Facts
Arbutus Biopharma Corp, Key Employees
Arbutus Biopharma Corp, Key Employee Biographies
Arbutus Biopharma Corp, Major Products and Services
Arbutus Biopharma Corp, History
Arbutus Biopharma Corp, Joint Venture
Arbutus Biopharma Corp, Key Competitors
Arbutus Biopharma Corp, Ratios based on current share price
Arbutus Biopharma Corp, Annual Ratios
Arbutus Biopharma Corp, Annual Ratios (Cont...1)
Arbutus Biopharma Corp, Interim Ratios
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Arbutus Biopharma Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Arbutus Biopharma Corp (ABUS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Deluxe Corporation (DLX):企業の財務・戦略的SWOT分析
    Deluxe Corporation (DLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Japan Airport Terminal Co Ltd:企業の戦略・SWOT・財務分析
    Japan Airport Terminal Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Airport Terminal Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Scholastic Corp (SCHL)
    Scholastic Corp (SCHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • GFI Informatique (GFI):企業の財務・戦略的SWOT分析
    GFI Informatique (GFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Corvia Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Corvia Medical Inc (Corvia), formerly DC Devices Inc is a medical device company that offers structural heart disease solutions. The company develops interatrial shunt device (IASD), a trans-catheter device designed diastolic heart failure, also known as heart failure with preserved ejection …
  • Glanbia plc:企業のM&A・事業提携・投資動向
    Glanbia plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Glanbia plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Aoyama Trading Co., Ltd.:企業の戦略・SWOT・財務分析
    Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bengal Energy Ltd (BNG):企業の財務・戦略的SWOT分析
    Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets in Australia’s Cooper Basin and India’s Cauvery Basin. The company holds interest in Toooko …
  • Eydo Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Eydo Pharma SAS (Eydo Pharma) develops anti-bacterial medicines from essential oils and natural plant molecules for the treatment of infections caused by resistant bacteria. The company developed a pipeline of compounds and formulations such as EP1012, EP1010, EP1011, EP1014, EP1015, EP1020 …
  • Binex Co Ltd (053030):企業の財務・戦略的SWOT分析
    Summary Binex Co Ltd (Binex) is a provider of biologic and pharmaceutical products. The company provides products such as bisroot, digestive products, antispasmodic and antiulcer agents, NSAIDs, cardiovascular and urology drugs and hepatic protectors, among others. It offers cough and cold remedies, …
  • Xbrane Biopharma AB (XBRANE):企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • Provogue (India) Limited (PROVOGE):企業の財務・戦略的SWOT分析
    Provogue (India) Limited (PROVOGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Bacardi Limited:企業の戦略・SWOT・財務情報
    Bacardi Limited - Strategy, SWOT and Corporate Finance Report Summary Bacardi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Laboratory Corporation of America Holdings:企業の戦略・SWOT・財務分析
    Laboratory Corporation of America Holdings - Strategy, SWOT and Corporate Finance Report Summary Laboratory Corporation of America Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Baptist Memorial Health Care Corp:企業の戦略的SWOT分析
    Baptist Memorial Health Care Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Aker ASA (AKER):石油・ガス:M&Aディール及び事業提携情報
    Summary Aker ASA (Aker) is an industrial investment company that operates through Industrial Holdings and Financial Investments. It invests mainly in energy, environment, fisheries and marine biotech, and finance. Its Industrial Holdings include Aker Solutions ASA, Aker BP, Akastor ASA, Ocean Yield …
  • Brookshire Grocery Co:企業の戦略・SWOT・財務情報
    Brookshire Grocery Co - Strategy, SWOT and Corporate Finance Report Summary Brookshire Grocery Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Tidewater Inc (TDW):石油・ガス:M&Aディール及び事業提携情報
    Summary Tidewater Inc (Tidewater) is an an petroleum service company that offers offshore supply vessels and marine support services. The company's services include transport and supply of offshore material; anchor handling, towing and positioning; construction support; well stimulation, FPSO suppor …
  • Ingram Micro Inc.:企業の戦略的SWOT分析
    Ingram Micro Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析
    Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆